Clinical Trial Update: HCV + to HCV - Kidney Transplant [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial involving Hepatitis C and kidney failure in the context of kidney transplant was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Kidney Failure

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Kidney Failure, Hepatitis C | Phase 4 | Status: WITHDRAWN